Bliss GVS Pharma Ltd.
BSE: 506197 | Sector: Health care |
NSE: BLISSGVS | ISIN Code: INE416D01022 |
BSE 00:00 | 08 Aug | 78.00 |
-0.95 (-1.20%) |
OPEN
79.00 |
HIGH
79.00 |
LOW
78.00 |
NSE 00:00 | 08 Aug | 78.10 |
(%) |
OPEN
78.55 |
HIGH
79.15 |
LOW
77.80 |
OPEN | 79.00 |
PREVIOUS CLOSE | 78.95 |
VOLUME | 14887 |
52-Week high | 121.65 |
52-Week low | 66.25 |
P/E | 8.65 |
Mkt Cap.(Rs cr) | 810 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Half Yearly Result
Particulars (![]() |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
Net Sales/Income From Operations | 328.90 | 307.46 | 232.67 | 232.84 | 222.78 |
Other Income | 21.49 | 13.88 | 7.55 | 10.13 | 22.92 |
Total Income | 350.39 | 321.34 | 240.22 | 242.97 | 245.70 |
Total Expenditure | 278.39 | 248.76 | 186.19 | 187.86 | 180.88 |
Operating Profit | 71.99 | 72.58 | 54.03 | 55.11 | 64.82 |
Interest | 2.49 | 1.84 | 2.64 | 1.55 | 5.25 |
Gross Profit | 69.51 | 70.74 | 51.39 | 53.56 | 59.57 |
Depreciation | 6.92 | 6.93 | 6.88 | 6.88 | 4.47 |
PBT | 62.59 | 63.82 | 44.52 | 46.67 | 55.10 |
Tax | 15.67 | 17.30 | 11.76 | 10.76 | 16.30 |
Net Profit/(Loss) | 46.28 | 46.39 | 31.62 | 35.88 | 39.98 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 2.75 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 43.53 | 46.39 | 31.62 | 35.88 | 39.98 |
Equity Share Capital | 10.31 | 10.35 | 10.31 | 10.31 | 10.31 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 4.49 | 4.48 | 3.07 | 3.48 | 3.88 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices